Pricing Log in Create free account

Anbio Biotechnology (NNNN) vs Sanara MedTech Inc. (SMTI)

Anbio Biotechnology and Sanara MedTech Inc. are both Medical Instruments & Supplies companies. Anbio Biotechnology is the larger, with a market value of $474.8M against $322.4M — 1.5× the size. Across the 9 metrics below, Anbio Biotechnology leads on 6 and Sanara MedTech Inc. on 3.

Valuation

Metric NNNN SMTI Medical Instruments & Supplies median
P/E — n/m 33.75
P/S — 2.61 2.52
P/B n/m 36.18 2.48
Price to free cash flow n/m 64.42 25.19
EV/EBITDA n/m 27.44 14.62
EV/Sales n/m 2.91 2.88
Earnings yield — (11.19%) (2.67%)
Free cash flow yield 0.00% 1.55% 0.09%

Profitability

Metric NNNN SMTI Medical Instruments & Supplies median
Gross margin — 93.03% 54.29%
Operating margin — 7.67% 1.07%
Net margin — (29.15%) (1.61%)
Free cash flow margin 0.00% 4.10% 1.08%
Return on equity 0.00% (147.79%) (1.32%)
Return on assets 0.00% (38.13%) 0.00%
Return on invested capital 0.00% 13.49% 0.00%

Growth

Metric NNNN SMTI Medical Instruments & Supplies median
Revenue growth (TTM) — 12.96% 8.85%
EPS growth (last fiscal year) 150.00% (282.46%) 8.65%
Revenue growth, 5-year CAGR — 45.92% 9.17%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NNNN SMTI Medical Instruments & Supplies median
Debt to equity 0.00 5.86 0.10
Current ratio 344.45 2.58 2.48
Net debt to EBITDA (2.06) 2.55 0.89

Dividend

Metric NNNN SMTI Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric NNNN SMTI Medical Instruments & Supplies median
Market cap 474.84m 322.40m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack